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susceptible to antimicrobial agents. Data concerning resistance to
antimicrobial agents in clinical P. putida isolates are limited. To the
best of our knowledge we report for the ﬁrst time the isolation of
NDM-1-producing multidrug-resistant P. putida from a case of
acute gastroenteritis. The isolate showed resistance to a wide
range of antimicrobials, including ﬂuoroquinolones, third-
generation cephalosporins and carbapenems. The isolate also
exhibited multiple mutations in the quinolone resistance
determining region and showed the presence of qepA, blaTEM,
blaOXA1 and blaOXA7 genes. The present study highlights the
importance of looking for the relatively rare aetiological agents in
clinical samples that do not yield common pathogens.
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This is an open access artiIntroductionPseudomonas putida, a non-fermenting Gram-negative bacillus
belonging to the ﬂuorescent group of the genus Pseudomonas is
frequently found in the environment, along with other non-
fermenting Gram-negative organisms. Previously thought to
be of low pathogenicity [1], there are increasing reports of their
emergence as opportunistic human pathogens causing bacter-
aemia and sepsis in neonatal, neutropenic and cancer patients,
as well as in people with urinary tract infections [2,3]. Most
P. putida are susceptible to antimicrobial agents such as ﬂuo-
roquinolones, aminoglycosides and carbapenems [4]. In the
present study, we report the isolation of an NDM-1-producing
multidrug-resistant P. putida from a 2-month-old female child
admitted to a tertiary-care hospital with acute gastroenteritis in
Belgaum, South India. To the best of our knowledge this is the
ﬁrst report of isolation of NDM-1-producing multidrug-
resistant P. putida causing acute gastroenteritis.
A female child aged 2 months was admitted to the gastro-
enteritis ward of a tertiary-care hospital in Belgaum, Karnataka,
South India, with symptoms of acute gastroenteritis on 21 June
2013. She had had watery diarrhoea for 3 days along with
vomiting for 5 days, showed signs of acute dehydration and had
fever of 38.9°C. The fever was intermittent in nature, associ-
ated with chills and rigor. The patient was lethargic, restless and
had sunken eyes. The patient was put on rehydration therapy, a
stool sample was collected for laboratory investigations before
administration of any antibiotic at the hospital, and the patient
was later empirically treated for acute diarrhoea with oral
ciproﬂoxacin (50 mg) twice daily and metronidazole (25 mg)
thrice daily. She recovered and was discharged on 26 June 2013.
The stool sample was processed for isolation and identiﬁ-
cation of common enteric bacterial pathogens, which include
diarrheagenic Escherichia coli, Shigella sp., Salmonella sp., Vibrio
sp. following WHO 1987, and was subjected to ELISA for
rotavirus, RT-PCR for identiﬁcation of common viral pathogens
like norovirus, astrovirus and sapovirus [5]. The sample was
also subjected to routine microscopy for detection of various
parasites like Ascaris lumbricoides, Giardia lamblia, Trichuris tri-
chiura, hook worm and Entamoeba histolytica. The isolate was
subjected to identiﬁcation based on an automated microbial
identiﬁcation system, (Vitec2 Compact; bioMérieux, Marcy
l’Etoile, France) which was also used for carrying out Antibiotic
sensitivity testing (AST) as per CLSI norms [6]. The identity of
the isolate was also conﬁrmed by genotypic-based method of
16S rRNA gene sequencing as deﬁned earlier [7]. The rabbit ileal
loop test was carried out for the isolate essentially as described
by Koley et al [8]. The volume of the accumulated ﬂuid inNew Microbe and New Infect 2015; 5: 5–9
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measured, and the extent of the ﬂuid accumulation was
expressed as mL/cm. The ileal loop test was performed with
positive and negative controls being Vibrio cholerae O1
(N16961) and phosphate-buffered saline, respectively.
The isolate was further screened for any mutation in the
quinolone resistance determining region following an earlier
described protocol (Table 1) [9]. Presence of plasmid-mediated
quinolone resistance determinants was screened following
standard conditions (Table 1) [10]. The isolate was also sub-
jected to PCR for detection of the presence of various β-lactam
resistance genes (blaTEM, blaSHV, blaCTX-M-3, blaOXA1 and blaOXA7)
following techniques reported previously (Table 1) [10]. Pres-
ence of the NDM-1 gene was determined by PCR using pub-
lished primers (Table 1) as described earlier [11]. All PCR
products were subjected to nucleotide sequencing in an auto-
matic sequencer (ABI 3130; Applied Biosystems, Foster City,
CA, USA) following the manufacturer’s instructions. Contig
sequences were aligned and edited with SEQSCAPE v2.7 (Applied
Biosystems) and compared in BLAST of the NCBI database.
Culture on thiosulphate citrate bile salt sucrose agar and
Hektoen enteric agar plates did not yield any isolate whereas on
McConkey agar, a pure culture of non-lactose-fermenting col-
onies appeared. The isolate was identiﬁed as P. putida by an
automated microbial identiﬁcation system, which was conﬁrmed
by 16s rRNA sequence analysis. The sample was negative for all
other bacteria, viruses and parasites tested. Growth of the or-
ganism as sole pathogen in the culture media in the absence ofTABLE 1. Details of the primers, ampliﬁcation temperature and am
Sl No. Gene Oligonucleotide sequence (50 –30)
1 NDM-1 ACCGCCTGGACCGATGACCA
GCCAAAGTTGGGCGCGGTTG
2 gyrA GACGGCCTGAAGCCGGTGCAC
GCCCACGGCGATACCGCTGGA
3 gyrB AGTACTTCGCCGACTTCCT
TACAGGCGCGACAGGCGCTT
4 parC TCTACGCCATGAGCGAACTGG
AGCAGCACCTCGGAA TAGCG
6 qnrA ATTTCTCACGCCAGGATTTG
GATCGGCAAAGGTTAGGTCA
7 qnrB GATCGTGAAAGCCAGAAAGG
ATGAGCAACGATGCCTGGTA
8 qnrC GGGTTGTACATTTATTGAATCG
CACCTACCCATTTATTTTCA
9 qnrS GCAAGTTCATTGAACAGGGT
TCTAAACCGTCGAGTTCGGCG
10 aac (60)-Ib-cr TTGCGATGCTCTATGAGTGGCTA
CTCGAATGCCTGGCGTGTTT
11 qepA AACTGCTTGAGCCCGTAGAT
GTCTACGCCATGGACCTCAC
12 blaTEM GAGTATTCAACATTTTCGT
ACCAATGCTTAATCAGTGA
13 blaSHV TCGCCTGTGTATTATCTCCC
CGCAGATAAATCACCACAATG
14 blaCTX-M-3 AATCACTGCGTCAGTTCAC
TTTATCCCCCACAACCCAG
15 blaOXA1 GCAGCGCCAGTGCATCAAC
CCGCATCAAATGCCATAAGTG
16 blaOXA7 AGTTCTCTGCCGAAGCC
TCTCAACCCAACCAACCC
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colonization of the gut of the patient by P. putida, probably
through suppression of normal microbiota. The P. putida isolate
showed resistance to a wide range of antimicrobials, including
ﬂuoroquinolones, third-generation cephalosporins and carba-
penems, according to CLSI breakpoint [6]. The isolate showed a
MIC (mg/L) of 32 for Ampicillin-sulbactam (SAM), 128 for
Ticarcillin (TIC),128 for Piperacillin (PIP),64 for Ceftazidime
(CAZ), 64 for Ceftriaxone (CRO), 64 for Cefepime (FEP),
16 for Imipenem (IMP), 16 for Meropenem (MEM), 16 for
Amikacin (AMK), 32 for Gentamicin (GEN), 16 for Tobra-
mycin (TOB), 4 for Ciproﬂoxacin (CIP), 8 for Levoﬂoxacin
(LVX), 16 for Tetracycline (TET), 8 for Tigecycline (TGC)
and 320 for Co-trimoxazole (CoT).
The isolate was tested and found positive for the production
of extended spectrum β-lactamase using the combination disc
test using ceftazidime-clavulanic acid (30/10 μg) and ceftriaxone
-clavulanic acid (30/10 μg) [10]. The 16S rRNA gene sequence of
this isolate was also compared with other sequences submitted
to the NCBI GenBank to understand its genetic relationship
with other P. putida by neighbour-joining phylogenetic analysis
using MEGA 5.2 software [12], which showed 100% similarity
to P. putida isolated from various other parts of the world
(Fig. 1). The isolate resulted in moderate ﬂuid accumulation
(0.35 mL/cm), which was higher than the negative control
(0.05 mL/cm) and lower than the positive control (1.2 cm/mL).
The isolate exhibited amino acid substitution of T83I and
S136A in gyrA; E469D in gyrB; and T105P, V124A and S136A inplicon size used in the study
Ampliﬁcation temp (°C) Amplicon size (bp)
58°C 264
64°C 417
739
262
64°C 516
476
307
428
55°C 482
596
50°C 857
768
701
198
591
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FIG. 1. Phylogenetic analysis based on the 16s rRNA gene sequence
of the Pseudomonas putida (J0018) isolate.
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further showed the presence of blaTEM, blaOXA1 and blaOXA7
genes. The isolate harboured the NDM-1 gene and the partial
sequence of the gene showed 100% nucleotide/amino acid
identity with those reported from other organisms isolated
from various other parts of India and elsewhere in the world.
Since the aetiological agent in this case was resistant to the
antibiotic used for therapy, it appears that the disease was self-
limiting and resolved on its own within 9 days of onset, and the
infant recovered as a result.
This is likely to be the ﬁrst report of the presence ofNDM-1 in
P. putida. Studies on antimicrobial resistance in P. putida are
scarce. In accordance with one such earlier report [9] we
detected multiple mutations in the quinolone resistance deter-
mining region of the ﬂuoroquinolone-resistant P. putida. OXA1
and OXA7, which code for oxacillinases, are plasmid-mediated
enzymes and were detected in an ampicillin-resistant isolate of
Escherichia coli [13]. QepA, a plasmid-mediated efﬂux pump
found in a clinical isolate of E. coli from Japan, is known to elevate
levels of resistance to several clinically important FQs, such as© 2015 New Microbes and New Infections published by Elsevier Ltd on b
This is an open access articiproﬂoxacin, norﬂoxacin and veterinary enroﬂoxacin [14]. The
spread of the opportunistic pathogens carrying NDM-1 gene
seems to have become a major global health threat. Reports of
microbes previously regarded as non-pathogenic, causing acute
diarrhoea in humans is a cause of concern [15]. Although in the
present study P. putida was isolated as sole pathogen in the cul-
ture media, further in-depth studies are required to understand
the potential of this bacterium to cause gastroenteritis as an in-
dependent pathogen. The presence of plasmid-mediated resis-
tance determinants in P. putida, which is a well-established
bioremediation agent [16,17], adds to the worry as these
potent genes may spread to other susceptible bacteria, making
them highly resistant. The data highlight the fact that the overuse
of antibiotics that are excreted by patients and so ﬁnd their way
into hospital and community wastewater systems provides an
environmental selection pressure for the emergence and
persistence of multidrug-resistant and pan-drug-resistant bac-
teria [18]. NDM-1-positive strains can destroy carbapenem an-
tibiotics such as meropenem, imipenem, doripenem and
ertapenem by breaking down the carbapenem groups ofehalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI, 5, 5–9
cle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
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ment of antibiotic-resistant bacterial infections. Therefore, the
spread of the NDM-1 gene to potentially non-pathogenic mi-
croorganisms now becomes potentially a major global health
threat [11].
Nevertheless, the distinction between causality of microbial
resistance and the rate of spread of resistance must be recog-
nized if we are to create a true solution to the problem of
antibiotic resistance [19]. If these underlying resistance genes
are transferred into otherwise susceptible bacteria, this can lead
to therapeutic failure as a consequence of antimicrobial resis-
tance, which may pose a real threat in the near future for the
developing countries where antibiotic misuse is common.
Emergence of newer mechanisms of resistance under heavy use
of antibiotics in resource-poor countries is likely to complicate
diagnosis for lesser known pathogens and their therapeutic
management. Now is the time for government and health ofﬁ-
cials to stop the blame game and act together towards a possible
solution by undertaking various programmes of antibiotic sur-
veillance and awareness among clinicians, veterinarians and the
general public, otherwise we will be headed towards a post-
antibiotic era as recently mentioned by WHO (http://apps.
who.int/iris/bitstream/10665/112642/1/9789241564748_eng.
pdf). Although further studies are required to establish or
conﬁrm the role of this microorganism as an independent
pathogen of gastroenteritis, our report also highlights the
importance of looking for the relatively rare aetiological agents
in clinical samples that do not yield common pathogens.
Our study once again highlights the problem of transfer of
multidrug-resistant genes, including the NDM-1 gene, to these
otherwise non-pathogenic bacteria, which calls for serious and
rapid implementation of strict antibiotic use policies. There is
an urgent need to address the lack of effective treatments to
meet the increasing public health burden caused by multidrug-
resistant bacteria, in particular against newly emerging patho-
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